These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Ability to tune out irrelevant information is impaired in AD. Love R Lancet Neurol; 2005 Nov; 4(11):702. PubMed ID: 16265795 [No Abstract] [Full Text] [Related]
9. Cognitive decline in Alzheimer disease: Impact of spirituality, religiosity, and QOL. Kaufman Y; Anaki D; Binns M; Freedman M Neurology; 2007 May; 68(18):1509-14. PubMed ID: 17470754 [TBL] [Abstract][Full Text] [Related]
10. Apathy and loss of insight in Alzheimer's disease: a SPECT imaging study. Ott BR; Noto RB; Fogel BS J Neuropsychiatry Clin Neurosci; 1996; 8(1):41-6. PubMed ID: 8845700 [TBL] [Abstract][Full Text] [Related]
11. Effects of cilostazol on cognition and regional cerebral blood flow in patients with Alzheimer's disease and cerebrovascular disease: a pilot study. Sakurai H; Hanyu H; Sato T; Kume K; Hirao K; Kanetaka H; Iwamoto T Geriatr Gerontol Int; 2013 Jan; 13(1):90-7. PubMed ID: 22672107 [TBL] [Abstract][Full Text] [Related]
12. Education and the course of cognitive decline in Alzheimer disease. Wilson RS; Li Y; Aggarwal NT; Barnes LL; McCann JJ; Gilley DW; Evans DA Neurology; 2004 Oct; 63(7):1198-202. PubMed ID: 15477538 [TBL] [Abstract][Full Text] [Related]
13. Benefits of combining donepezil plus traditional Japanese herbal medicine on cognition and brain perfusion in Alzheimer's disease: a 12-week observer-blind, donepezil monotherapy controlled trial. Maruyama M; Tomita N; Iwasaki K; Ootsuki M; Matsui T; Nemoto M; Okamura N; Higuchi M; Tsutsui M; Suzuki T; Seki T; Kaneta T; Furukawa K; Arai H J Am Geriatr Soc; 2006 May; 54(5):869-71. PubMed ID: 16696770 [No Abstract] [Full Text] [Related]
14. Asymmetry of brain metabolism and cognitive function. Haxby JV; Rapoport SI Geriatr Nurs; 1985; 6(4):200-3. PubMed ID: 3847376 [No Abstract] [Full Text] [Related]
15. Vascular cognitive impairment. Gilbert DT West Indian Med J; 2007 Dec; 56(6):479-80. PubMed ID: 18646488 [No Abstract] [Full Text] [Related]
16. Characteristic deterioration of ADAS-Jcog subscale scores and correlations with regional cerebral blood flow reductions in Alzheimer's disease. Yoshii F; Kawaguchi C; Kohara S; Shimizu M; Onaka H; Ryo M; Takahashi W Neurol Sci; 2018 May; 39(5):909-918. PubMed ID: 29508099 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic effects of CDP-choline in Alzheimer's disease. Cognition, brain mapping, cerebrovascular hemodynamics, and immune factors. Cacabelos R; Caamaño J; Gómez MJ; Fernández-Novoa L; Franco-Maside A; Alvarez XA Ann N Y Acad Sci; 1996 Jan; 777():399-403. PubMed ID: 8624120 [TBL] [Abstract][Full Text] [Related]
18. Oral temperature change and cognitive decline in Alzheimer's patients. Collins KJ J Am Geriatr Soc; 1996 Sep; 44(9):1135-6. PubMed ID: 8790252 [No Abstract] [Full Text] [Related]
19. Cognitive and Functional Decline in Patients With Mild Alzheimer Dementia With or Without Comorbid Diabetes. Ascher-Svanum H; Chen YF; Hake A; Kahle-Wrobleski K; Schuster D; Kendall D; Heine RJ Clin Ther; 2015 Jun; 37(6):1195-205. PubMed ID: 25676448 [TBL] [Abstract][Full Text] [Related]
20. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia. Yew B; Nation DA; Brain; 2017 Jul; 140(7):1987-2001. PubMed ID: 28575149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]